Clinical Trials
6
Active:1
Completed:1
Trial Phases
1 Phases
Not Applicable:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (100.0%)Study of Transcatheter Aortic Valve Replacement With A² Flex and Commissural Alignment Technology in Severe Aortic Stenosis
Not Applicable
Not yet recruiting
- Conditions
- Aortic Stenosis Symptomatic
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Peijia Medical Technology (Suzhou) Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT06721676
- Locations
- 🇨🇳
Peiga Medical Technology (Suzhou) Co., Ltd, Suzhou, Jiangsu 215025, Suzhou, Jiangsu, China
Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR)
Not Applicable
Recruiting
- Conditions
- Aortic Regurgitation
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Peijia Medical Technology (Suzhou) Co., Ltd.
- Target Recruit Count
- 116
- Registration Number
- NCT06101888
- Locations
- 🇨🇳
Beijing Anzhen Hospital, Beijing, Beijing, China
🇨🇳Fu Wai Hospital, Beijing, China, Beijing, Beijing, China
🇨🇳Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation
Not Applicable
Recruiting
- Conditions
- Degenerative Mitral Valve DiseaseMitral Regurgitation
- First Posted Date
- 2022-12-19
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Peijia Medical Technology (Suzhou) Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT05655897
- Locations
- 🇨🇳
Peiga Medical Technology (Suzhou) Co., Suzhou, Jiangsu, China
Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China
Not Applicable
Recruiting
- Conditions
- Mitral Regurgitation
- First Posted Date
- 2022-11-09
- Last Posted Date
- 2022-11-09
- Lead Sponsor
- Peijia Medical Technology (Suzhou) Co., Ltd.
- Target Recruit Count
- 110
- Registration Number
- NCT05610566
- Locations
- 🇨🇳
Peiga Medical Technology (Suzhou) Co., Suzhou, Jiangsu, China
Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis
Not Applicable
Active, not recruiting
- Conditions
- Aortic Stenosis
- First Posted Date
- 2021-03-25
- Last Posted Date
- 2023-10-24
- Lead Sponsor
- Peijia Medical Technology (Suzhou) Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT04815785
- Locations
- 🇨🇳
Peiga Medical Technology (Suzhou) Co., Ltd, Suzhou, Jiangsu, China
- Prev
- 1
- 2
- Next
News
No news found